U.S. Video

Ennaid CEO on cutting through the FDA's red tape

42 Mins Ago

CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan's pricing of the EpiPen and the FDA's guidelines for drug development.